おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SR One
company
About
SR One is the corporate venture capital arm of GlaxoSmithKline.
- 1 - 10
Highlights
Details
- Industries
- Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 1985
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- CVC
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantlyimpact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Investments
Number of Investments
Number of Lead Investments
7
4
SR One has made 7 investments. Their most recent investment was on
Nov 17, 2022, when Rezo Therapeutics raised $78M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 17, 2022
Rezo Therapeutics
|
Series A | $78M | Biotechnology | Yes |
|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
|
Oct 3, 2019
Arcellx
|
Series B | $85M | Biopharma | — |
|
Jun 5, 2018
Nimbus Therapeutics
|
Series C | $65M | Biotechnology | Yes |
|
Mar 19, 2015
Nimbus Therapeutics
|
Series B | $43M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
